×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Artifacts
/
gaps-als-immune-signature-stratification
📖
gaps-als-immune-signature-stratification
wiki page
Created: 2026-04-06T11:32:34
By: crosslink-v2
Quality:
80%
✓ SciDEX
ID: wiki-gaps-als-immune-signature-stratific
Linked Artifacts (74)
mentions
🔬
What are the mechanisms underlying tdp-43 phase separation t
75%
mentions
🔬
What are the mechanisms underlying rna binding protein dysre
75%
mentions
🔬
CRISPR-based therapeutic approaches for neurodegenerative di
75%
mentions
🔬
Analyze the spectrum of microglial activation states (DAM, h
75%
mentions
🔬
CRISPR-based therapeutic approaches for neurodegenerative di
75%
mentions
🔬
RNA binding protein dysregulation across ALS FTD AD
75%
mentions
🔬
TDP-43 undergoes liquid-liquid phase separation that becomes
75%
mentions
🔬
RNA binding protein dysregulation across ALS FTD and AD
75%
mentions
🧫
cGAMP biomarker analysis in ALS patient spinal cord samples
70%
mentions
🧫
TDP-43 mutant mouse model cGAS/STING pathway analysis
70%
mentions
🧫
cGAMP biomarker analysis in ALS patient spinal cord samples
70%
mentions
🧫
TDP-43 mitochondrial invasion and mtDNA release in iPSC moto
70%
mentions
🧫
cGAS/STING pathway activation by TDP-43-released mtDNA
70%
mentions
🧫
s:** - Temporal analysis showing mitochondrial defects prece
70%
mentions
🧫
Proposed experiment from debate on TDP-43 undergoes liquid-l
70%
mentions
🧫
s:** - Single-cell RNA-seq to measure editing efficiency acr
70%
mentions
🧫
Metabolic Pathway-Targeted Therapy in ALS
70%
mentions
🧫
ALS Progression Rate Heterogeneity — mechanism and biomarker
70%
mentions
🧫
ALS Regional Onset and Spread: Network-Level Staging Model
70%
mentions
🧫
Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk
70%
mentions
🧫
Autophagy Enhancement Drug Screening for Neurodegeneration
70%
mentions
🧫
Blood Biomarker vs Tau PET for Treatment Monitoring
70%
mentions
🧫
Blood-Brain Barrier Aging and Neurodegeneration — From Leaka
70%
mentions
🧫
Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT
70%
mentions
🧫
C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study
70%
mentions
🧫
Environmental Exposure Causal Attribution in ALS — Experimen
70%
mentions
🧫
Experiment Index
70%
mentions
🧫
Microbiome-Gut Barrier Signatures in ALS — Experiment Design
70%
mentions
🧫
Multiscale Computational Modeling of Protein Aggregation Kin
70%
mentions
🧫
Pre-Symptomatic Tau Detection in MAPT Mutation Carriers
70%
mentions
🧫
Pre-Symptomatic Detection and Intervention Timing in Genetic
70%
mentions
🧫
Experiment Scoring Methodology
70%
mentions
🧫
Sleep and Respiratory Network Interaction in ALS — Experimen
70%
mentions
🧫
TDP-43 PET Ligand Development for FTD and ALS
70%
mentions
🧫
Viral and Post-Infectious Mechanisms in ALS — Experiment Des
70%
related
🔬
What are the mechanisms underlying tdp-43 phase separation t
67%
related
🔬
What are the mechanisms underlying rna binding protein dysre
67%
related
🔬
CRISPR-based therapeutic approaches for neurodegenerative di
67%
related
🔬
Analyze the spectrum of microglial activation states (DAM, h
67%
related
🔬
CRISPR-based therapeutic approaches for neurodegenerative di
67%
related
🔬
RNA binding protein dysregulation across ALS FTD AD
67%
related
🔬
TDP-43 undergoes liquid-liquid phase separation that becomes
67%
related
🔬
RNA binding protein dysregulation across ALS FTD and AD
67%
related
🧫
cGAMP biomarker analysis in ALS patient spinal cord samples
63%
related
🧫
TDP-43 mutant mouse model cGAS/STING pathway analysis
63%
related
🧫
cGAMP biomarker analysis in ALS patient spinal cord samples
63%
related
🧫
TDP-43 mitochondrial invasion and mtDNA release in iPSC moto
63%
related
🧫
cGAS/STING pathway activation by TDP-43-released mtDNA
63%
related
🧫
s:** - Temporal analysis showing mitochondrial defects prece
63%
related
🧫
Proposed experiment from debate on TDP-43 undergoes liquid-l
63%
related
🧫
s:** - Single-cell RNA-seq to measure editing efficiency acr
63%
related
🧫
Metabolic Pathway-Targeted Therapy in ALS
63%
related
🧫
ALS Progression Rate Heterogeneity — mechanism and biomarker
63%
related
🧫
ALS Regional Onset and Spread: Network-Level Staging Model
63%
related
🧫
Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk
63%
related
🧫
Autophagy Enhancement Drug Screening for Neurodegeneration
63%
related
🧫
Blood Biomarker vs Tau PET for Treatment Monitoring
63%
related
🧫
Blood-Brain Barrier Aging and Neurodegeneration — From Leaka
63%
related
🧫
Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT
63%
related
🧫
C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study
63%
related
🧫
Environmental Exposure Causal Attribution in ALS — Experimen
63%
related
🧫
Experiment Index
63%
related
🧫
Microbiome-Gut Barrier Signatures in ALS — Experiment Design
63%
related
🧫
Multiscale Computational Modeling of Protein Aggregation Kin
63%
related
🧫
Pre-Symptomatic Tau Detection in MAPT Mutation Carriers
63%
related
🧫
Pre-Symptomatic Detection and Intervention Timing in Genetic
63%
related
🧫
Experiment Scoring Methodology
63%
related
🧫
Sleep and Respiratory Network Interaction in ALS — Experimen
63%
related
🧫
TDP-43 PET Ligand Development for FTD and ALS
63%
related
🧫
Viral and Post-Infectious Mechanisms in ALS — Experiment Des
63%
mentions
🧪
TREM2-Dependent Microglial Senescence Transition
50%
mentions
🧫
Microglial TREM2 Agonist In Vivo Efficacy
44%
mentions
🧫
TREM2 Agonist Therapy for Parkinson's Disease — Experim
44%
mentions
🧫
TREM2 Function in Alzheimer's Disease — From Risk Varia
44%